News: Suppliers
28 September 2026
Riber’s first-half revenue grows 19% year-on-year to €12.7m
Molecular beam epitaxy (MBE) system maker Riber S.A. of Bezons, France has confirmed 19% growth in revenue from €10.7m in first-half 2025 to €12.7m for first-half 2026, driven by strong momentum in Services & Accessories and resilient Systems sales.
Services & Accessories revenue rose by 71% from €3m to €5.1m.
Systems revenue was €7.7m, roughly level with first-half 2025’s €7.8m (for three machines delivered in each case).
Growth returns firm to profitability
Gross margin has risen from 36.2% to 39.8%.
Reflecting the revenue growth, higher gross margin, and disciplined operating expense management, net income has improved by €1m, from a loss of €0.8m in first-half 2025 to a profit of €0.2m in first-half 2026. This includes net financial income of €0.1m.
At the end of June, the cash position was €5.2m, up on €2.5m at end-June 2025 but down from €7.5m at end-December.
Shareholders’ equity has fallen from €27.3m at year-end 2025 to €25.7m at end-June 2026, due mainly to a €2.1m distribution to shareholders from the issue premium account in June.
Financial debt (excluding IFRS 16) amounts to €6.4m, compared with €1.4m at end-December 2025 and €2.3m at end-June 2025. This includes €6m in bank borrowings arranged during first-half 2026 with Bpifrance and leading French banks.
Net debt (the cash position net of all financial debt, excluding IFRS 16) therefore amounted to €1.2m at end-June 2026, compared with net cash of €0.2m a year earlier.
Bank loans enable continued industrialization of ROSIE
Having secured the €6m in bank financing, Riber is continuing to implement its strategic roadmap.
The ROSIE (RIBER Oxide Silicon Epitaxy) platform is dedicated to the growth of functional oxides on 300mm silicon wafers, designed in accordance with SEMI industry standards. The technology targets integrated silicon photonics, with potential applications in electro-optical components for telecoms and data centers, as well as in certain quantum architectures. The second ROSIE system was shipped in July to a major quantum computing player in the USA.
Riber is now accelerating the industrialization of ROSIE II, a dual-chamber cluster production platform that is the next stage of development of ROSIE. “We are also reaching an important milestone, with the support of our financial partners, as we move forward with the construction of ROSIE II. This new platform will enable us to accelerate process qualification and prepare for technology’s commercial deployment,” notes chair & CEO Annie Geoffroy.
The system will support further technological maturation of the platform, accelerate the qualification of BTO/STO (barium titanate oxide/strontium titanate oxide) processes under industrial operating conditions, and prepare the technology for commercial rollout.
Riber says that it may use this first ROSIE II system to produce technology wafers or allocate it to an industrial customer. The first BTO/STO samples developed through the partnership with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) will be available in fourth-quarter 2026. Riber says that several laboratories and industrial companies have confirmed their interest in technology through wafer pre-orders.
In addition, Riber has been invited to participate in the establishment of major industrial and technological partnerships, helping to support the development of new applications.
“We are continuing to strengthen our product offering by combining epitaxy and deposition technologies and developing process automation solutions,” says Geoffroy. “We are therefore continuing to execute our roadmap, with the ambition of strengthening our offering around our established technologies and developing new opportunities in photonics, quantum technologies and advanced deposition technologies.”
Order book
Riber says that commercial activity remains strong, particularly in applications related to datacom and quantum technologies.
At end-June, the total order book was €26.8m, down 3% on €27.7m a year ago, impacted by export restrictions to Asia (which prevented more than €8m in orders from being secured) and longer decision-making cycles at certain customers.
Systems orders are down by 27% from €22.5m to €16.5m, comprising four systems (three production systems and one ROSIE platform). However, this excludes the order announced on 9 July for a production system in Europe, scheduled for delivery in 2027.
Services & Accessories orders almost doubled, from €5.2m to €10.3m. This growth was supported in particular by sales of spare parts for recently ordered equipment, as well as several upgrade projects for long-standing customers in North America.
“The first half of 2026 confirms the strength of our core business in an international environment that remains complex,” says Geoffroy. “Strong momentum in Services & Accessories, together with sustained interest in our technologies, are encouraging signs,” she adds.
Full-year 2026 outlook
Riber reiterates that its sales remain structurally seasonal, with deliveries traditionally weighted toward the second half of the year, so first-half results cannot be extrapolated to the full year.
The firm says that its addressable markets continue to benefit from favorable structural trends, particularly in photonics, artificial intelligence and quantum technologies. It also continues to see sustained demand for its Services & Accessories. Subject to obtaining an export license for Asia, Riber expects full-year 2026 revenue to be broadly in line with 2025.
Governance
At its meeting on 22 September, Riber’s board of directors acknowledged the resignation of Nicolas Grandjean as an independent director for professional reasons. The board thanks Grandjean for his contribution to its work and for his commitment throughout his term of office.
Riber’s revenue grows 19% in first-half 2026, driven by 71% growth in Services & Accessories
Riber’s net income grows 27% in 2025 to €5.2m, despite revenue falling by 2%
